Finally, since we detected a significant reduction in VAPB protein levels in the ALS cases, we analysed the impact of this reduction on the VAPB-PTPIP51 interaction by normalising the VAPB-PTPIP51 PLA dot numbers to VAPB protein levels. This evidence concerns the gene RMDN3 and amyotrophic lateral sclerosis.